Observational study / 2012
Dietary acrylamide intake was positively associated with multiple myeloma and follicular lymphoma in men, but not in women.
In the Netherlands Cohort Study on diet and cancer involving 120,852 men and women, researchers investigated dietary acrylamide intake and lymphatic malignancy risk over 16.3 years of follow-up (1,233 confirmed cases). In men, hazard ratios per 10 µg/day increment of acrylamide were 1.14 (95% CI: 1.01, 1.27) for multiple myeloma and 1.28 (95% CI: 1.03, 1.61) for follicular lymphoma. Among never-smoking men, the hazard ratio for multiple myeloma was 1.98 (95% CI: 1.38, 2.85). No associations were observed for women.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 120,852 men and women followed since September 1986
- What was measured
- Risk of histological subtypes of lymphatic malignancies
THE PAPER
Dietary acrylamide intake and the risk of lymphatic malignancies: the Netherlands Cohort Study on diet and cancer.
Bongers ML, Hogervorst JG, Schouten LJ, Goldbohm RA, Schouten HC, van den Brandt PA. PLoS One, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.